Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy
Open Access
- 1 January 2006
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 12 (23) , 3682-3694
- https://doi.org/10.3748/wjg.v12.i23.3682
Abstract
Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsyKeywords
This publication has 117 references indexed in Scilit:
- Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis CJournal of Hepatology, 2006
- Experts' opinions on the role of liver biopsy in HCV infection: A Delphi survey by the Italian Association of Hospital Gastroenterologists (A.I.G.O.)Journal of Hepatology, 2005
- Towards more individualised management of hepatitis C virus patients with initially or persistently normal alanineaminotransferase levelsJournal of Hepatology, 2005
- Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patientsJournal of Hepatology, 2004
- Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis CHepatology, 2004
- Coarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus-related chronic hepatitisJournal of Hepatology, 2004
- SLC11A1 promoter gene polymorphisms and fibrosis progression in chronic hepatitis CGut, 2004
- Sampling Variability of Liver Fibrosis in Chronic Hepatitis CHepatology, 2003
- Tru‐cut and Menghini needles: different yield in the histological diagnosis of liver diseaseLiver International, 1985
- Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosisDigestive Diseases and Sciences, 1983